Skip to Main Content

Author Details

Bj??rn G Voldborg
Technical University of Denmark
1995
28
12
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36755049Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain α-neurotoxins from snakes.Nat Commun2023
37442299Characterisation of two snake toxin-targeting human monoclonal immunoglobulin G antibodies expressed in tobacco plants.Toxicon2023
37205389Inferring secretory and metabolic pathway activity from omic data with secCellFie.bioRxiv2023
36610518CHOGlycoNET: Comprehensive glycosylation reaction network for CHO cells.Metab Eng2023
36823021Assessing developability early in the discovery process for novel biologics.MAbs2023
35099088Highly Selective Lysine Acylation in Proteins Using a Lys-His Tag Sequence.Chemistry2022
33169829In situ detection of protein interactions for recombinant therapeutic enzymes.Biotechnol Bioeng2021
34056395Compartmentalized Proteomic Profiling Outlines the Crucial Role of the Classical Secretory Pathway during Recombinant Protein Production in Chinese Hamster Ovary Cells.ACS Omega2021
32502629High throughput generation of a resource of the human secretome in mammalian cells.N Biotechnol2020
31896772Genome-scale reconstructions of the mammalian secretory pathway predict metabolic costs and limitations of protein secretion.Nat Commun2020
33351794CHOmics: A web-based tool for multi-omics data analysis and interactive visualization in CHO cell lines.PLoS Comput Biol2020
32710928Independent component analysis of E. coli's transcriptome reveals the cellular processes that respond to heterologous gene expression.Metab Eng2020
32285041A Markov model of glycosylation elucidates isozyme specificity and glycosyltransferase interactions for glycoengineering.Curr Res Biotechnol2020
30513349Glyco-engineered CHO cell lines producing alpha-1-antitrypsin and C1 esterase inhibitor with fully humanized N-glycosylation profiles.Metab Eng2019
31772123The human secretome.Sci Signal2019
32577618Increased mAb production in amplified CHO cell lines is associated with increased interaction of CREB1 with transgene promoter.Curr Res Biotechnol2019
31222165Combating viral contaminants in CHO cells by engineering innate immunity.Sci Rep2019
27860290Predictive glycoengineering of biosimilars using a Markov chain glycosylation model.Biotechnol J2017
28074024Whole-Genome Sequencing of Invasion-Resistant Cells Identifies Laminin α2 as a Host Factor for Bacterial Invasion.mBio2017
27883890A Consensus Genome-scale Reconstruction of Chinese Hamster Ovary Cell Metabolism.Cell Syst2016
24462685Human chitotriosidase CHIT1 cross reacts with mammalian-like substrates.FEBS Lett2014
25249625SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression.Nucleic Acids Res2014
24896608Biochemical characterization of human gluconokinase and the proposed metabolic impact of gluconic acid as determined by constraint based metabolic network analysis.PLoS One2014
21130169Screening of genetic parameters for soluble protein expression in Escherichia coli.Protein Expr Purif2011
21414287Predictive mutagenesis of ligation-independent cloning (LIC) vectors for protein expression and site-specific chemical conjugation.Anal Biochem2011
15173183Insertion of foreign T cell epitopes in human tumor necrosis factor alpha with minimal effect on protein structure and biological activity.J Biol Chem2004
9496384Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials.Ann Oncol1997
8722035Recognition determinants for proteins and antibiotics within 23S rRNA.Biochem Cell Biol1995
  • 1 - 28 of 28

Recommended Authors

Monash Biomedicine Discovery Institute, Monash University
Career Start Year 2008
Number of shared co-authors 2
Genentech Inc.
Career Start Year 2006
Number of shared co-authors 2
Karolinska Institutet
Career Start Year 2005
Number of shared co-authors 7
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 2004
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2001
Number of shared co-authors 0
Stanford University
Career Start Year 2000
Number of shared co-authors 3
Karolinska Institutet
Career Start Year 1999
Number of shared co-authors 3
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1999
Number of shared co-authors 0
Helmholtz Centre for Infection Research
Career Start Year 1998
Number of shared co-authors 0
Fluidigm Corporation
Career Start Year 1997
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1997
Number of shared co-authors 0
Pfizer Inc.
Career Start Year 1997
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 1995
Number of shared co-authors 0
Princeton University
Career Start Year 1993
Number of shared co-authors 2
Boehringer Ingelheim RCV GmbH & Co. KG
Career Start Year 1993
Number of shared co-authors 1
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 0
CNRS, Aix-Marseille Universite
Career Start Year 1992
Number of shared co-authors 0
Argonne National Laboratory
Career Start Year 1992
Number of shared co-authors 0
Stanford University
Career Start Year 1992
Number of shared co-authors 2
Institute of Microbiology of the CAS
Career Start Year 1991
Number of shared co-authors 0
Lund University Cancer Centre
Career Start Year 1989
Number of shared co-authors 4
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 0
University of Cape Town
Career Start Year 1988
Number of shared co-authors 1
Vrije Universiteit Amsterdam (VU)
Career Start Year 1987
Number of shared co-authors 0
Biodesign Institute, Arizona State University
Career Start Year 1986
Number of shared co-authors 5
University of Oxford
Career Start Year 1986
Number of shared co-authors 0
Weizmann Institute of Science
Career Start Year 1983
Number of shared co-authors 0
University of Rome 'Tor Vergata'
Career Start Year 1976
Number of shared co-authors 0
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 1974
Number of shared co-authors 1
Monash University
Career Start Year 1971
Number of shared co-authors 4

Collaborators

University of California San Diego
Co-authored papers 11
University of California San Diego
Co-authored papers 5
university of california san diego
Co-authored papers 4
Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Co-authored papers 3
KTH Royal Institute of Technology
Co-authored papers 2
KTH Royal Institute of Technology
Co-authored papers 2
KTH - Royal Institute of Technology
Co-authored papers 2
KTH Royal Institute of Technology, AlbaNova University Centre
Co-authored papers 2
The Royal Institute of Technology (KTH)
Co-authored papers 2
KTH-Royal Institute of Technology
Co-authored papers 2
KTH Royal Institute of Technology
Co-authored papers 2
KTH - Royal Institute of Technology
Co-authored papers 2
Chalmers University of Technology
Co-authored papers 2
KTH - Royal Institute of Technology
Co-authored papers 2
KTH - Royal Institute of Technology
Co-authored papers 2
KTH - Royal Institute of Technology
Co-authored papers 2
KTH - Royal Institute of Technology
Co-authored papers 2
KTH-Royal Institute of Technology
Co-authored papers 2
KTH Royal Institute of Technology
Co-authored papers 2
KTH-Royal Institute of Technology
Co-authored papers 2
Novo Nordisk Research Center Seattle Inc., Inc.
Co-authored papers 2
Co-authored papers 2
KTH Royal Institute of Technology
Co-authored papers 2
Sahlgrenska University Hospital
Co-authored papers 1
Jiangsu University Zhenjiang 212013
Co-authored papers 1
AlbaNova University Center, KTH-Royal Institute of Technology
Co-authored papers 1
university of california san diego School of Medicine
Co-authored papers 1
Karolinska Institute
Co-authored papers 1
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
Beijing Friendship Hospital, Capital Medical University
Co-authored papers 1